Jubilant Pharmova Limited (JUBLPHARMA.NS) NSE

975.05

-12.5(-1.27%)

Updated at June 02 03:29PM

Currency In INR

Jubilant Pharmova Limited

Address

1A, Sector 16A

Noida, 201301

India

Phone

91 12 0436 1000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

5399

First IPO Date

July 01, 2002

Key Executives

NameTitlePayYear Born
Naresh KapoorCompany Secretary & Compliance Officer6.86M1974
Rajagopal SankaraiahAdvisor67.29M1959
Priyavrat BhartiaMD & Director74.96M1976
Arjun Shanker BhartiaJoint MD & Director74.96M1987
A. SrivastavaSenior Vice President of Corporate Affairs01946
Ashish MukkirwarChief Financial Officer0N/A
Chandan Singh SengarPresident of Life Science Chemicals01964
Pankaj DhawanVP & Head of Investor Relations0N/A
Shantanu JhaGroup Chief Human Resources Officer0N/A
Arun Kumar SharmaChief Financial Officer & Group Treasurer01966
Prakash Chandra BishtExecutive Vice President of Group Accounts01964
Sanjay GuptaExecutive Vice President & Head of Legal01966

Description

Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is headquartered in Noida, India.